Related Experiment Video
Updated: May 17, 2025

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Pathological Study of a Case of Catastrophic Antiphospholipid Syndrome in a Patient With Gastrointestinal Bleeding
Brian Shih1, Qi Zhang2,3, Hao Li2
1Medical School, Schulich School of Medicine, London, CAN.
Abstract:
Catastrophic antiphospholipid syndrome (CAPS) is a very rare, life-threatening form of antiphospholipid syndrome (APS) characterized by multiorgan vascular occlusive events that occur rapidly in succession or simultaneously. Here, we describe a rare case of CAPS in a 67-year-old woman with a 26-year history of APS managed on therapeutic doses of warfarin presenting to hospital with a four-day history of melena secondary to gastrointestinal bleed. She was treated endoscopically, provided vitamin K for warfarin reversal, and started on dalteparin daily. During her course in hospital, she developed dyspnea and hypoxia with bilateral pleural effusions. The patient concurrently became increasingly hemodynamically unstable. She was treated with furosemide and broad-spectrum antibiotics but deteriorated, experienced cardiac arrest, and could not be successfully resuscitated. On autopsy, widespread microthrombi in cardiac, pulmonary, and cerebral tissues were identified and a diagnosis of CAPS was made. This case highlights the difficulty and importance of recognizing clinical manifestations of CAPS and balancing the risk for thrombosis when patients are undergoing treatment for concurrent serious health issues.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

